Understanding S-HPFH: A Milder Path Forward
At a Glance
S-HPFH (Sickle Cell-Hereditary Persistence of Fetal Hemoglobin) is a very mild form of sickle cell disease. People with S-HPFH continue making protective fetal hemoglobin throughout their lives, acting as a natural shield against the severe pain crises and complications seen in classic sickle cell.
Discovering a diagnosis that includes the words “Sickle Cell” can be an overwhelming experience. It is natural to feel a wave of fear or confusion when looking at a newborn screening result or a laboratory report [1][2]. Most of the information available to the public about sickle cell disease focuses on HbSS (Sickle Cell Anemia), the most severe form of the condition. However, S-HPFH (Sickle Cell-Hereditary Persistence of Fetal Hemoglobin) is a distinct and significantly milder condition that often allows individuals to live a life free of the complications typically associated with sickle cell disease [3][4].
Understanding S-HPFH
To understand S-HPFH, it helps to look at the two parts of the name:
- Sickle Cell (S): You have inherited one gene for hemoglobin S (sickle hemoglobin).
- Hereditary Persistence of Fetal Hemoglobin (HPFH): You have inherited a genetic trait that keeps your body’s “baby” hemoglobin (fetal hemoglobin or HbF) turned “on” for your entire life [5].
Normally, the body stops making fetal hemoglobin shortly after birth and switches to adult hemoglobin. In S-HPFH, the “switch” never flips. This is a powerful advantage. Because your body continues to produce high levels of fetal hemoglobin, it acts as a natural shield that prevents the sickle hemoglobin from causing problems [6][7]. For a deeper dive into how this shield works, read The Biology of Protection.
Three Reasons for Peace of Mind
While it is important to stay connected with a hematologist (a blood specialist), research highlights three major reasons why S-HPFH is considered a benign or very mild condition:
- A “Pancellular” Shield: In S-HPFH, fetal hemoglobin is distributed pancellularly, meaning it is present in nearly every single red blood cell [5][8].
- Protection Against Major Complications: The severe complications often associated with sickle cell disease—such as bone infarctions (bone tissue death), severe vaso-occlusive crises (pain crises), and major lung problems—are extremely rare in people with S-HPFH [4][3].
- Near-Normal Quality of Life: Most individuals with S-HPFH are asymptomatic, meaning they do not feel sick or show physical signs of the disease [3][9].
Moving Forward with Confidence
The initial anxiety of a “Sickle Cell” report is often a result of the medical system’s need to flag any variation in hemoglobin. In the case of S-HPFH, this variation is actually a protective factor [7]. Genetic counseling is often recommended to help families understand the inheritance (discussing family planning, inheritance probabilities, and genetic testing options) and to confirm the diagnosis [1][2]. To understand how the diagnosis is confirmed, read Decoding Your Labs. Finally, you and your care team can focus on Tailoring Your Care Plan to reflect the mild nature of the condition.
In this guide
3 chapters
The Biology of Protection: How S-HPFH Works
Learn how S-HPFH protects you from sickle cell disease. Understand how high levels of fetal hemoglobin block sickling, pancellular distribution, and testing.
Decoding Your Labs: From "FS" to S-HPFH
Learn how to read your S-HPFH lab reports and newborn screening results. Understand what an FS result means, the role of HbF, and why genetic testing matters.
Staying Healthy: Standard of Care for S-HPFH
Learn about the standard of care for S-HPFH. Understand why standard sickle cell treatments may not be needed, recommended monitoring, and family planning.
Common questions in this guide
What exactly is S-HPFH?
Is S-HPFH as severe as classic sickle cell anemia?
Will I have symptoms with an S-HPFH diagnosis?
Do I still need to see a hematologist if S-HPFH is mild?
How do I confirm if my child has S-HPFH instead of classic sickle cell?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Can we schedule a genetic counseling session to fully understand the inheritance patterns of S-HPFH?
- 2.Does the lab report conclusively show S-HPFH, or do we need further genetic testing?
- 3.What is the best way to communicate my S-HPFH status to other doctors or emergency room staff?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (9)
- 1
Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Sickle Cell Anemia.
Shook LM, Haygood D, Quinn CT
Frontiers in medicine 2021; (8()):734305 doi:10.3389/fmed.2021.734305.
PMID: 34859003 - 2
Blessing in disguise; a case of Hereditary Persistence of Fetal Hemoglobin.
Shaukat I, Pudal A, Yassin S, et al.
Journal of community hospital internal medicine perspectives 2018; (8(6)):380-381 doi:10.1080/20009666.2018.1536241.
PMID: 30559951 - 3
The Natural History of Hb S/Hereditary Persistence of Fetal Hemoglobin in 13 Children from the State of Minas Gerais, Brazil.
Belisário AR, Sales RR, Silva CM, et al.
Hemoglobin 2016; (40(3)):215-9 doi:10.3109/03630269.2016.1149076.
PMID: 27117574 - 4
A Rare Case of Multiple Bone Infarctions and Abnormal Pulmonary Function Tests in a Patient With Compound Heterozygous Hemoglobin S and Type 2 Hereditary Persistence of Fetal Hemoglobin.
Alnaqbi KA
Cureus 2024; (16(8)):e66395 doi:10.7759/cureus.66395.
PMID: 39113817 - 5
Fetal Hemoglobin in Sickle Hemoglobinopathies: High HbF Genotypes and Phenotypes.
Steinberg MH
Journal of clinical medicine 2020; (9(11)) doi:10.3390/jcm9113782.
PMID: 33238542 - 6
Fetal hemoglobin rescues ineffective erythropoiesis in sickle cell disease.
El Hoss S, Cochet S, Godard A, et al.
Haematologica 2021; (106(10)):2707-2719 doi:10.3324/haematol.2020.265462.
PMID: 32855279 - 7
Sickle cell disease severity: an introduction.
Pace BS, Goodman SR
Experimental biology and medicine (Maywood, N.J.) 2016; (241(7)):677-8 doi:10.1177/1535370216641880.
PMID: 27190296 - 8
CRISPR/Cas9 gene editing for curing sickle cell disease.
Park SH, Bao G
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2021; (60(1)):103060 doi:10.1016/j.transci.2021.103060.
PMID: 33455878 - 9
β-Hemoglobinopathies: The Test Bench for Genome Editing-Based Therapeutic Strategies.
Barbarani G, Łabedz A, Ronchi AE
Frontiers in genome editing 2020; (2()):571239 doi:10.3389/fgeed.2020.571239.
PMID: 34713219
This page provides educational information about S-HPFH. It does not replace professional medical advice. Always consult your hematologist or genetic counselor regarding your specific diagnosis and care plan.
Get notified when new evidence is published on Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.